WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that consolidated revenue for the three months ended March 31, 2009 increased 41% year-over-year to $22.4 million, excluding discontinued operations. Safeguard’s consolidated net loss from continuing operations attributable to common shareholders in the quarter was $10.3 million, or $0.08 per share, compared with a loss of $11.8 million, or $0.10 per share, for the same period of 2008.
